Overview

Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery

Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
0
Participant gender:
Female
Summary
Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functions
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Benha University
Treatments:
Mosapride
Criteria
Inclusion Criteria:

- all women undergoing elective cesarean section

Exclusion Criteria:

- prior abdominal surgery, abdominal adhesion, chronic constipation, allergy to
mosapride